20/20 Biolabs, Inc. (AIDX)
NASDAQ · Healthcare
20/20 Biolabs, Inc. Total Liabilities 2024–2025
20/20 Biolabs, Inc. annual/quarterly total liabilities history from 2024 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- 20/20 Biolabs, Inc. total liabilities for the quarter ending December 31, 2025 were 4.2M, a 99.94% increase year-over-year.
- 20/20 Biolabs, Inc. total liabilities for 2025 were 4.2M, a 99.94% increase from 2024.
- 20/20 Biolabs, Inc. total liabilities for 2024 were 2.1M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| 20/20 Biolabs, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $4 |
| 2024 | $2 |
| 20/20 Biolabs, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $4 |
| 2024-12-31 | $2 |
20/20 Biolabs, Inc. Total Liabilities — FAQ
20/20 Biolabs, Inc. (AIDX) total liabilities over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AIDX's total liabilities history?
The chart and table above show 20/20 Biolabs, Inc.'s total liabilities by year and by quarter, including the growth rate.